Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2553-2558

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welt, F. G. P.
Right arrow Articles by Rogers, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welt, F. G. P.
Right arrow Articles by Rogers, C.
Related Collections
Right arrow Restenosis
Right arrow Animal models of human disease
Right arrow Smooth muscle proliferation and differentiation
Right arrow Heparin
Right arrow Catheter-based coronary interventions: stents
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2553.)
© 2000 American Heart Association, Inc.


Vascular Biology

Neutrophil, Not Macrophage, Infiltration Precedes Neointimal Thickening in Balloon-Injured Arteries

Frederick G. P. Welt; Elazer R. Edelman; Daniel I. Simon; Campbell Rogers

From the Department of Medicine (Cardiac Catheterization Laboratory and Coronary Care Unit, Cardiovascular Division, Brigham and Women’s Hospital) Harvard Medical School (F.G.P.W., E.R.E., D.I.S., C.R.), Boston, Mass; the Harvard-M.I.T. Division of Health Sciences and Technology, Massachusetts Institute of Technology (F.G.P.W., E.R.E., C.R.), Cambridge, Mass; the West Roxbury Veteran’s Affairs Medical Center (F.G.P.W.), West Roxbury, Mass; and the Clinical Investigator Training Program: Harvard-MIT Division of Health Sciences and Technology-Beth Israel Deaconess Medical Center, in collaboration with Pfizer Inc (F.G.P.W.), Groton, Conn.

Correspondence to Frederick G.P. Welt, MD, Harvard-MIT Division of Health Sciences and Technology, MIT, 16-343, Cambridge, MA 02139. E-mail welt{at}mediaone.net

Abstract—Macrophages are abundant after stent-induced arterial injury. Inhibition of macrophage recruitment blocks neointimal growth in this model. In contrast, after superficial injury from balloon endothelial denudation, macrophages are sparse. However, many anti-inflammatory therapies remain effective against neointimal growth after balloon injury. To investigate further the role of leukocytes after injury, 41 New Zealand White rabbits underwent iliac artery balloon denudation. In 18, subcutaneous pumps were placed to deliver intravenous heparin (0.3 mg/kg per hour). Arteries were harvested at 6 hours and at 3, 7, and 14 days. In 8 animals, either M1/70 (a monoclonal antibody [mAb] against adhesion molecule Mac-1) or a nonspecific IgG was given (5 mg/kg IV bolus and then 1 mg/kg SC QOD), and arteries were harvested at 6 hours and 3 days. Computer-aided morphometry was performed as was immunohistochemistry to assess smooth muscle cell (SMC) proliferation (bromodeoxyuridine-positive cells), neutrophil content (RPN357, mAb against rabbit neutrophil/thymocyte), and macrophage content (RAM-11, mAb against rabbit macrophage). Heparin inhibited neointimal growth at 7 and 14 days (64% and 32.5% reduction, respectively; P<0.05). Neutrophils were observed in the media early after balloon injury, and heparin and M1/70 inhibited this infiltration (82% and 83% reduction, respectively; P<0.05 each) with a coincident inhibition of medial SMC proliferation at 3 days (49% and 84% reduction, respectively; P<0.05 each). Macrophages were absent at all time points. Neutrophil, but not macrophage, infiltration occurs early after endothelial denudation. Inhibition of this process is associated with a reduction in medial SMC proliferation. These data suggest a central role for neutrophils in restenosis and help to explain prior reports of an inhibitory effect of anti-inflammatory therapies on neointimal growth after balloon injury.


Key Words: neutrophils • angioplasty • restenosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Meguro, H. Iida, H. Takano, T. Morita, M. Sata, R. Nagai, and T. Nakajima
Function and role of voltage-gated sodium channel NaV1.7 expressed in aortic smooth muscle cells
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H211 - H219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Li, J. M. Sanders, M. H. Bevard, Z. Sun, J. W. Chumley, E. V. Galkina, K. Ley, and I. J. Sarembock
CD40 Ligand Promotes Mac-1 Expression, Leukocyte Recruitment, and Neointima Formation after Vascular Injury
Am. J. Pathol., April 1, 2008; 172(4): 1141 - 1152.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Inoue, M. Sata, Y. Hikichi, R. Sohma, D. Fukuda, T. Uchida, M. Shimizu, H. Komoda, and K. Node
Mobilization of CD34-Positive Bone Marrow-Derived Cells After Coronary Stent Implantation: Impact on Restenosis
Circulation, February 6, 2007; 115(5): 553 - 561.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Sharony, G. Pintucci, P. C. Saunders, E. A. Grossi, F. G. Baumann, A. C. Galloway, and P. Mignatti
Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1651 - H1659.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
A. G. Touchard and R. S. Schwartz
Preclinical Restenosis Models: Challenges and Successes
Toxicol Pathol, January 1, 2006; 34(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Wang, M. Sakuma, Z. Chen, V. Ustinov, C. Shi, K. Croce, A. C. Zago, J. Lopez, P. Andre, E. Plow, et al.
Leukocyte Engagement of Platelet Glycoprotein Ib{alpha} via the Integrin Mac-1 Is Critical for the Biological Response to Vascular Injury
Circulation, November 8, 2005; 112(19): 2993 - 3000.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
P. H Chong and J. W. Cheng
Early Experiences and Clinical Implications of Drug-Eluting Stents: Part 1
Ann. Pharmacother., April 1, 2004; 38(4): 661 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Brickson, L. L. Ji, K. Schell, R. Olabisi, B. St. Pierre Schneider, and T. M. Best
M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage following stretch injury
J Appl Physiol, September 1, 2003; 95(3): 969 - 976.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Inoue, T. Uchida, I. Yaguchi, Y. Sakai, K. Takayanagi, and S. Morooka
Stent-Induced Expression and Activation of the Leukocyte Integrin Mac-1 Is Associated With Neointimal Thickening and Restenosis
Circulation, April 8, 2003; 107(13): 1757 - 1763.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
F. G. Welt, C. Tso, E. R. Edelman, M. A Kjelsberg, J. F Paolini, P. Seifert, and C. Rogers
Leukocyte recruitment and expression of chemokines following different forms of vascular injury
Vascular Medicine, February 1, 2003; 8(1): 1 - 7.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
D. E. Cutlip, M. S. Chauhan, D. S. Baim, K. K. L. Ho, J. J. Popma, J. P. Carrozza, D. J. Cohen, and R. E. Kuntz
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2082 - 2089.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. G.P. Welt and C. Rogers
Inflammation and Restenosis in the Stent Era
Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1769 - 1776.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. D. Danenberg, F. G. P. Welt, M. Walker III, P. Seifert, G. S. Toegel, and E. R. Edelman
Systemic Inflammation Induced by Lipopolysaccharide Increases Neointimal Formation After Balloon and Stent Injury in Rabbits
Circulation, June 18, 2002; 105(24): 2917 - 2922.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-W. Hwang and E. R. Edelman
Arterial Ultrastructure Influences Transport of Locally Delivered Drugs
Circ. Res., April 19, 2002; 90(7): 826 - 832.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Horvath, F. G.P. Welt, M. Nedelman, P. Rao, and C. Rogers
Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted
Circ. Res., March 8, 2002; 90(4): 488 - 494.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Szocs, B. Lassegue, D. Sorescu, L. L. Hilenski, L. Valppu, T. L. Couse, J. N. Wilcox, M. T. Quinn, J.D. Lambeth, and K. K. Griendling
Upregulation of Nox-Based NAD(P)H Oxidases in Restenosis After Carotid Injury
Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 21 - 27.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. G.P. Welt, T. C. Woods, and E. R. Edelman
Oral Heparin Prevents Neointimal Hyperplasia After Arterial Injury: Inhibitory Potential Depends on Type of Vascular Injury
Circulation, December 18, 2001; 104(25): 3121 - 3124.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Horvath, F. G.P. Welt, M. Nedelman, P. Rao, and C. Rogers
Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted
Circ. Res., March 8, 2002; 90(4): 488 - 494.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-W. Hwang and E. R. Edelman
Arterial Ultrastructure Influences Transport of Locally Delivered Drugs
Circ. Res., April 19, 2002; 90(7): 826 - 832.
[Abstract] [Full Text] [PDF]